Retail Clinics

DUBLIN, Ireland — Health Canada on Tuesday approved naloxone hydrochloride nasal spray, a nasal delivery method for the opioid overdose medication, which Adapt Pharma said it would market as Narcan Nasal Spray. 

 

NEW YORK — A recent survey from CityMD Urgent Care is finding that a lot of people aren’t planning on getting flu shots, and among millennials, slightly more than half of them don’t plan on getting vaccinated against the flu this year. 

 

ATLANTA — In its Morbidity and Mortality Weekly Report, the Centers for Disease Control and Prevention break down a survey about influenza vaccination among healthcare professionals, noting that employer vaccine requirements or on-site vaccination can help achieve better coverage. 

 

ST. PAUL, Minn. — Pharmacy benefit manager Prime Therapeutics recently analyzed pharmacy claims for short- and long-acting opioids, finding a decrease in short-acting opioid claims and an increase in long-acting opioid claims. The review of 15 million commercially insured members found an overall 3.9% decrease in opioid claims from 2014 to 2015. 

 

SILVER SPRING, Md. — The Food and Drug Administration has approved Janssen Pharmaceuticals’ Invokamet XR, a once-daily, extended-release combination therapy of Invokana (canagliflozin) and metformin, the company announced Wednesday. The drug is indicated as a first-line treatment to improve blood glucose control in adults with Type 2 diabetes alongside diet and exercise.